Drug Channels

JANUARY 14, 2022

He discusses an independent research organization’s study of the 340B rebate model’s impact on covered entities’ cash flow. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Jeremy describes Kalderos’ 340B rebate model. Read on for Jeremy’s insights. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Drugs Research 98

Drug Channels

FEBRUARY 2, 2024

Divya shares highlights from GoodRx’s new research report: The GoodRx Effect: How GoodRx Improves the Economics of Healthcare. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Today’s guest post comes from Divya Iyer, SVP of Go-to-Market Strategy at GoodRx. Read on for Divya’s insights.

Therapies 98

Therapies Marketing Research Drugs 98

Drug Channels

OCTOBER 4, 2022

The research was sponsored by the Association for Accessible Medicines (AAM). Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Last month, IQVIA quietly released a fascinating new report on discount cards. Link below.) There’s a lot to unpack about the growing discount card market. d/b/a Drug Channels Institute.

Marketing 98

Marketing Drugs Research Pharmacy 98

NIOSH Science Blog: Drugs

MAY 17, 2023

The National Mesothelioma Virtual Bank (NMVB) is a virtual biospecimen tissue biorepository that was developed in 2006 at the University of Pittsburgh in partnership with a network of sites in the mid-Atlantic region. It was created to assist researchers and healthcare professionals better understand and treat malignant mesothelioma.

Treatment 52

Treatment Research Disease 52

Drug Channels

APRIL 7, 2023

Today’s guest post comes from Heather Roulston, Market Research Manager at MMIT. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Using MMIT’s proprietary data, Heather demonstrates that contracting for medical benefit drugs is now common for many therapeutic areas. Read on for Heather’s insights.

Marketing 98

Marketing Production Drugs Research 98

Drug Channels

APRIL 29, 2022

Chris and Carolyn discuss the insights that health economics and outcomes research (HEOR) professionals bring to commercial teams. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. They explain how that pairing benefits both manufacturers and patients. Read on for Chris’ and Carolyn’s insights. d/b/a Drug Channels Institute.

Engineering 98

Engineering Drugs Research 98

SCIENMAG: Medicine & Health

AUGUST 21, 2023

FROM: James Urton Credit: NASA/MODIS Rapid Response Team/Goddard Space Flight Center FROM: James Urton University of Washington 206-543-2580 jurton@uw.edu (Note: researcher contact information at the end) For Immediate Release August 21, 2023 In 2006, the Tripod Complex Fire burned more than 175,000 acres in north-central Washington.

Research 87

Research Science 87

Drug Channels

AUGUST 12, 2022

Divya highlights new GoodRx research on the out-of-pocket cost gap between brand-name and generic prescriptions. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Today’s guest post comes from Divya Iyer, VP, Strategy and Business Development, Pharma Manufacturer Solutions at GoodRx. Read on for Divya’s insights.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceuticals Drugs Research 96

Drug Channels

DECEMBER 15, 2022

The research was sponsored by the Association for Accessible Medicines (AAM). Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channels Outlook 2023. Click here to see the original post and comments from October 2022.

Marketing 98

Marketing Drugs Research Pharmacy 98

Drug Channels

JANUARY 10, 2023

I also note some troubling research on the patient impact of exclusions—although much remains unknown. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Below, I highlight four takeaways from this year’s lists, including a look at biosimilar insulin and the forthcoming biosimilar competition for Humira.

Biosimilars 98

Biosimilars Pharmacy Drugs Production 98

Drug Channels

JUNE 14, 2022

Their research, along with a simultaneously released New York Times op-ed, received widespread media coverage. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Last week, the authors of a new JAMA study claimed that “prices for new drugs are skyrocketing.” Links below. Read on and consider what the data are really saying.

Drugs 98

Drugs Disease Pharmaceuticals Treatment 98

Drug Channels

FEBRUARY 27, 2024

In this issue: An update on the retail pharmacy shakeout Arguing for high drug prices A leading researcher provides a 340B reality check Physicians don’t want pharmacists getting uppity Plus, Dave Grohl fights for your right to…have healthcare price transparency? P.S. Join my nearly 53,000 LinkedIn followers for daily links to neat stuff.

Pharmacy 95

Pharmacy Drugs Research International 95

Drug Channels

AUGUST 8, 2023

Below, I include links to publicly available comments from a diverse range of stakeholders, including 340B Health, the American Hospital Association, Biotechnology Innovation Organization, Community Oncology Alliance, National Association of Community Health Centers, and Pharmaceutical Research and Manufacturers of America.

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

Drug Channels

MARCH 28, 2023

I also note some troubling research on the patient impact of exclusions—although much remains unknown. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Below, I highlight four takeaways from this year’s lists, including a look at biosimilar insulin and the forthcoming biosimilar competition for Humira.

Biosimilars 98

Biosimilars Pharmacy Drugs Production 98

Drug Channels

JANUARY 9, 2024

I also highlight recent research that raises troubling questions about the patient impact of these ever-growing exclusion lists. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for my deep dive into these two therapeutic categories. All rights reserved.

Biosimilars 98

Biosimilars Pharmacy Production Drugs 98

Drug Channels

AUGUST 16, 2024

Click here to learn more about MMIT’s Custom Market Research offering for biosimilar manufacturers. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. The findings shed light on payers' view of biosimilar conpetition, contracting challenges, and other issues. All rights reserved.

Biosimilars 78

Biosimilars Marketing Production Research 78

Drug Target Review

APRIL 4, 2024

About the author Dr Nicholas Waters, Head of R&D, IRLAB Dr Nicholas Waters worked as a PhD student in Nobel Laureate Professor Arvid Carlsson’s research group at the Department of Pharmacology, Göteborg University (1987-1995). In 1998, he co-founded Carlsson Research.

Disease 105

Disease Treatment Licensing Licensing 105

Quanticate

MAY 16, 2024

Clinical research thrives on standardised processes, and one crucial aspect is the adherence to the Clinical Data Acquisition Standards Harmonization (CDASH). First developed in 2006, CDASH plays a vital role in establishing harmonized standards for the collection and submission of data from clinical studies.

Clinical Research 59

Clinical Research Research 59

Alta Sciences

MARCH 4, 2025

This was in 2006, at a time when the FDA guidances on these topics had not yet been published. Prior to joining Altasciences, Beatrice worked as a research scientist in Toronto, Canada, and was responsible for providing scientific input on various specialty Phase I/II clinical trialsincluding abuse potential studies for CNS drugs.

Clinical Trials 52

Clinical Trials FDA Drug Development Trials 52

The Pharma Data

MAY 17, 2021

In a separate Research Letter, Simon J. Gunter, MPhil, and his colleagues at the PORTAL research group provides an analysis of the effect of market exclusivity of drugs under FDA’s Unapproved Drug Initiative (UDI). The median exclusivity of UDI-approved drugs was 3.42

Research 52

Research FDA Approval Drugs FDA 52

Drug Target Review

NOVEMBER 1, 2023

2 Implication of ATX in a large range of human diseases have been highlighted by both fundamental research and clinical trials. 1-5 Implication of ATX in a large range of human diseases have been highlighted by both fundamental research and clinical trials. He is a researcher at University of Oldenburg, Germany. J Med Chem.

Clinical Trials 134

Clinical Trials Trials Small Molecule Disease 134

Drug Channels

MARCH 5, 2024

The potential effect of the IRA on manufacturers’ new drug research and development strategies is beyond the scope of this webinar. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Fein will focus on the IRA’s patient and commercial market impacts. All rights reserved.

Pharmacy 98

Pharmacy Biosimilars Drugs Marketing 98

Drug Channels

APRIL 4, 2022

Copyright © 2006-2022 Pembroke Consulting, Inc. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). d/b/a Drug Channels Institute.

Disease 98

Disease Therapies FDA Trials 98

Drug Channels

JULY 11, 2023

Consistent with our previous research, five multi-billion-dollar, for-profit, publicly traded pharmacy chains and PBMs— CVS Health, Walgreens, Cigna (via Express Scripts), UnitedHealth Group (via OptumRx), and Walmart —account for 75% of all 340B contract pharmacy relationships with covered entities. d/b/a Drug Channels Institute.

Pharmacy 74

Pharmacy Marketing Hospitals Drugs 74

Drug Target Review

FEBRUARY 28, 2024

Preclinical research on γδ T cells has made great strides since the cells were first identified in the 1980s, with γδ T-cell therapies from several companies, including IN8bio, now in or nearing clinical trials for various cancers. from 2003 to 2006, covering the biotechnology and life-science tools sectors.

Therapies 105

Therapies Engineering Molecular Biology Science 105

Drug Target Review

MARCH 5, 2024

The first true test of my commitment came with my PhD in Biophysics as a scholar at the International Max-Planck Research School, specifically when I became pregnant with my first child in 2006. Could you share an example of a specific project or research that you have worked on and the impact it has had in your field?

Engineering 105

Engineering Production International Science 105

Drug Channels

AUGUST 25, 2021

Recent topics have included: Express Scripts’ 2022 formulary exclusion list, Amazon’s pharmacy, generics in Part D, 340B research, zero-dollar copay, pass-through rebates, PBMs’ spread pricing, Rite Aid’s Bartell deal, healthcare pricing trends, the DSCSA, John Venn, and more. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc.

Biosimilars 64

Biosimilars Pharmacy Drugs Research 64

DS in Pharmatics

MARCH 22, 2023

The Biomedical Advanced Research and Development Authority (BARDA) is) probably best known for its role in Operation Warp Speed and subsequent efforts to accelerate the manufacturing of COVID-19 vaccines. BARDA, formed in 2006, anticipated threats such as the COVID-19 pandemic.

Production 52

Production Vaccine Research 52

Drug Channels

MARCH 15, 2022

Twice a year, I research and write two comprehensive, fact-based, and nonpartisan reports on drug channel economics. Copyright © 2006-2022 Pembroke Consulting, Inc. If you preordered the report, you should have already received an email with download instructions last week. Please contact us if you did not receive the email.

Pharmacy 98

Pharmacy Specialty Pharmacies Licensing Licensing 98

Drug Channels

MAY 16, 2024

They discussed new GoodRx research and had a candid discussion about their daily challenges in caring for patients—especially those living with diabetes and obesity. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Minisha Sood. Parikh and Sood. Read on for Preeti’s insights.

Research 52

Research Drugs 52

Drug Channels

JUNE 13, 2024

Chris discusses new research on how patients perceive out-of-pocket costs. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Today’s guest post comes from Christine Juday, Head of Market Access at Real Chemistry. Read on for Chris' insights. All rights reserved.

Marketing 52

Marketing Drugs Research 52

Drug Channels

DECEMBER 5, 2021

Join us and learn how adding customized data and alerting can drive opportunities for enhancing your research, real-world data, precision medicine, and more. Copyright © 2006-2021 Pembroke Consulting, Inc. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., d/b/a Drug Channels Institute.

Production 75

Production Science Drugs Research 75

BMG Labtech

FEBRUARY 28, 2023

1 This finding, which arose from curiosity-driven research, opened new areas of enquiry, led to a better understanding of epigenetics, and launched a host of clinical investigations for new drugs to treat cancer, inflammation, and neurological diseases.

FDA 52

FDA Treatment Disease Marketing 52

Drug Channels

DECEMBER 11, 2020

She also introduces us to Ontada , a new McKesson business that uses technology, real-world data, and research capabilities as a way to accelerate innovation and improve cancer therapies. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. To learn more, visit the Ontada website. d/b/a Drug Channels Institute.

Drug Development 52

Drug Development Clinical Trials Drugs Trials 52

Drug Target Review

NOVEMBER 23, 2023

These are all conditions involving problems with neuropeptide signalling, and a lot of research focuses on particular neuropeptide pathways that affect these behaviours. He obtained his PhD in Biochemistry from the University of California, Berkeley and began work on nematode neurobiology as a postdoctoral researcher at UCSF.

Therapies 98

Therapies Molecular Biology Laboratories Government 98

Drug Channels

SEPTEMBER 13, 2021

Copyright © 2006-2021 Pembroke Consulting, Inc. The content-rich agenda features fresh perspectives, along with many of the well-respected experts typically on the program. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Compliance 75

Compliance Drugs Regulations Science 75

Drug Target Review

JUNE 12, 2023

Leveraging AI-guided structure-based drug design, Insilico’s research and development team generated an impressive portfolio of over 6,000 molecules and identified three highly promising hit series. He is an adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.

Metabolic Stability 92

Metabolic Stability Clinical Trials Small Molecule Pharmacokinetics 92